Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REFERENCES<br />
Savory J., Herman M. M. and Ghribi O. (2006) <strong>Mechanisms</strong> <strong>of</strong> alum<strong>in</strong>um-<strong>in</strong>duced<br />
234<br />
neurodegeneration <strong>in</strong> animals: Implications for Alzheimer's disease. J. Alzheimers Dis. 10,<br />
135–144.<br />
Schaefer K., von Herrath D., Erley C. M. (1988) Treatment <strong>of</strong> uremic hyperphosphatemia–is<br />
there still a need for alum<strong>in</strong>um salts? Am. J. Nephrol. 8, 173–178.<br />
Schapira A. H. V. (1999) Science, medic<strong>in</strong>e, and the future: Park<strong>in</strong>son's disease. BMJ 318, 311–<br />
314.<br />
Schapira A. H. (2008) Mitochondria <strong>in</strong> the aetiology and pathogenesis <strong>of</strong> Park<strong>in</strong>son's disease.<br />
Lancet Neurol. 7, 97–109.<br />
Schapira A. H., Mann V. M., Cooper J. M., Krige D., Jenner P. J. and Marsden C. D. (1992)<br />
Mitochondrial function <strong>in</strong> Park<strong>in</strong>son’s disease. The Royal K<strong>in</strong>gs and Queens Park<strong>in</strong>son’s<br />
Disease Research Group. Ann. Neurol. 32, S116–S124.<br />
Schipper H. M., Liberman A. and Stopa E. G. (1998) Neural heme oxygenase-1 expression <strong>in</strong><br />
idiopathic Park<strong>in</strong>son’s disease. Exp. Neurol. 150, 60–68.<br />
Schmidt W. J. and Kretschmer B. D. (1997) Behavioural pharmacology <strong>of</strong> glutamate receptors<br />
<strong>in</strong> the basal ganglia. Neurosci. Biobehav. Rev. 21, 381–392.<br />
Schoenberg B. S., Osuntokun B. O., Adeuja A. O., Bademosi O., Nottidge V., Anderson D. W.<br />
and Haerer A. F. (1988) Comparison <strong>of</strong> the prevalence <strong>of</strong> Park<strong>in</strong>son’s disease <strong>in</strong> black<br />
populations <strong>in</strong> the rural United States and <strong>in</strong> rural Nigeria: door-to-door community<br />
studies. Neurology 38, 645–646.<br />
Schrag A., Dodel R., Spottke A., Bornsche<strong>in</strong> B., Siebert U. and Qu<strong>in</strong>n N. P. (2007) Rate <strong>of</strong> cl<strong>in</strong>ical<br />
progression <strong>in</strong> Park<strong>in</strong>son’s disease. A prospective study. Mov. Disord. 22, 938–945.<br />
Schulz J. B. and Dichgans J. (1999) Molecular pathogenesis <strong>of</strong> movement disorders: are prote<strong>in</strong><br />
aggregates a common l<strong>in</strong>k <strong>in</strong> neuronal degeneration. Curr. Op<strong>in</strong>. Neurol. 12, 433–439.